BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15487447)

  • 21. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical significance of cyclin B1 expression in adult acute leukemia patients].
    Ma WD; Xu SR; Guo XN; Jia JS; Xue F
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):523-6. PubMed ID: 14690581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis.
    Faretta M; Bergamaschi D; Taverna S; Ronzoni S; Pantarotto M; Mascellani E; Cappella P; Ubezio P; Erba E
    Cytometry; 1998 Jan; 31(1):53-9. PubMed ID: 9450525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; GarcĂ­a JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma.
    Harada H; Omura K; Nakajima Y; Hasegawa S; Mogi S
    J Exp Clin Cancer Res; 2006 Sep; 25(3):351-6. PubMed ID: 17167975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
    Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
    Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
    Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
    Gulubova M; Vlaykova T
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer.
    Egloff AM; Weissfeld J; Land SR; Finn OJ
    Ann N Y Acad Sci; 2005 Dec; 1062():29-40. PubMed ID: 16461786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease.
    Suzuki H; Graziano DF; McKolanis J; Finn OJ
    Clin Cancer Res; 2005 Feb; 11(4):1521-6. PubMed ID: 15746055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
    Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis.
    Valera VA; Walter BA; Yokoyama N; Koyama Y; Iiai T; Okamoto H; Hatakeyama K
    Ann Surg Oncol; 2007 Jan; 14(1):34-40. PubMed ID: 17024555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Okadaic acid induced cyclin B1 expression and mitotic catastrophe in rat cortex.
    Chen B; Cheng M; Hong DJ; Sun FY; Zhu CQ
    Neurosci Lett; 2006 Oct; 406(3):178-82. PubMed ID: 16919876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
    Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Burnet NG; Coleman N
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):455-66. PubMed ID: 16150117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Messerini L; Cianchi F; Cortesini C; Comin CE
    Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.